Menu

An Obesity-Cancer Link?

Why obese individual are more likely to get cancer could be partly explained by a gene that activates both pathways.

Nov 22, 2011
Edyta Zielinska

FLICKR, JILL A. BROWN

A gene variant found in some 30 percent of type 2 diabetics can inhibit the action of p53—the gatekeeper of the cell cycle and one of the most commonly mutated genes across cancers, according to research from Lund University Diabetes Centre.

The gene TCF normally protects insulin-producing ß-cells from damage due to excess sugar exposure. But a number of diabetics have a variant of this gene that impairs the cell’s ability to secrete insulin, eventually killing the ß-cell, thus leading to diabetes.

In a study published in the journal Human Molecular Genetics, the researchers looked for the molecules that interacted with the TCF variant and noticed that one of them was p53. When they blocked TCF in the cell, the levels of p53 went up, demonstrating a link between the cancer-related gene and TCF.  When TCF isn’t blocked, p53 expression is suppressed, rendering cells much more likely to accumulate mutations during division that could lead to cancer.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.